Informa £2.24bn Clarion takeover|9% share dilution that lifts earnings per share?

The dilution puzzle

Informa is buying the events organiser Clarion from Blackstone for £2.24 billion, part-funded by a £940 million share sale. The new shares add about 9 per cent to Informa's share count. Yet the company says its earnings per share will rise in 2027 as a result. Clarion owns more than 100 event brands, from the IFA Berlin electronics show to the DSEI defence fair and the ICE gaming event.

To help pay for it, Informa is also pausing the share buyback it had been running. A big share sale usually puts a lid on a share price, as an analysis by Proactive Investors noted on the day. Informa's shares rose instead. Alliance News listed them up 3.2 per cent, among the FTSE 100's biggest risers. My reading is that this is not the squeeze on shareholders that a big share sale usually signals.

On Informa's own figures, the new shares look set to buy more profit than they give away. Start with what worries a shareholder in any share sale. When a company issues about 9 per cent more shares, each existing share owns a smaller slice of it. Here, though, the share sale is the smaller part of the funding. It raises £940 million. Set against a £2.24 billion price, that covers about 42 per cent.

The remaining £1.3 billion or so comes from committed acquisition financing. In plain terms, borrowing. And what the money buys is sizeable. Informa expects Clarion to make at least £575 million of revenue in 2027. It expects an adjusted operating margin above 30 per cent. That implies at least £173 million of operating profit, a calculation Proactive Investors also made.

That is how dilution and rising earnings can sit together. Clarion's profit is shared among only about 9 per cent more shares, because lenders fund most of the price. Informa expects a mid-single-digit lift to adjusted diluted earnings per share in 2027. The cost is the debt. Informa expects net debt to stay below three times EBITDA at the end of 2026.

EBITDA is operating profit before interest, tax, depreciation and amortisation. Informa expects the ratio to fall below 2.5 times by the end of 2027. Small holders were not simply left on the sidelines. UK investors could buy the new shares on the same pricing basis as institutions, with a minimum of £250. Applications were open through ISAs and SIPPs where platforms supported them.

So the first answer is that the dilution is modest next to what it buys. But the stake has grown. Each share now carries a slice of a larger debt, as well as a larger business.

What Informa paid for

Informa is paying 11.1 times Clarion's expected 2027 EBITDA. Tom Ward, a media and internet expert quoted by Proactive Investors, said that broadly matches comparable deals. He put it at about 15 per cent of Informa's own enterprise value. Ward called it Informa's biggest deal since it bought UBM for £3.8 billion in 2018.

Informa also quotes a lower figure: about nine times, once £50 million of annual cost savings are counted. Working back from the headline multiple, Clarion's expected EBITDA comes to roughly £200 million. So the savings Informa is counting on equal about a quarter of Clarion's own expected earnings. Nor was Clarion a hurried sale. Blackstone launched a process to sell it in 2025, Reuters reported, citing sources.

In other words, Informa paid a market price. The cheaper multiple is not something it bought. It is something it has to build. Informa's chief executive, Stephen Carter, framed the deal as leadership. He said the combination 'will underscore Informa as the UK-listed, international leader in B2B Live Events'. Clarion's chief executive, Lisa Hannant, framed it as recognition.

She said Informa's decision to invest in Clarion 'is a recognition of the quality of our business, our brands and our people'. Neither statement mentions the overlapping costs the combination is meant to remove. Yet those savings are the gap between 11 times and nine. City AM reported that Informa expects £50 million of cost savings by 2029. It also expects roughly £25 million of extra income.

Hannant stays on and joins Informa's executive team, with a key role in the integration. Ward said Informa's record on integrating acquisitions offers some comfort. Informa targets a post-tax return on invested capital above 10 per cent by 2029. It says that is ahead of its cost of capital. So the claim narrows. The new shares buy more profit than they give away only if those savings arrive on time.

What shareholders give up

There is a second cost, quieter than dilution. Informa said it 'will pause its current share buyback programme in order to redirect capital to fund the transaction'. A buyback shrinks the share count, so each remaining share claims more of the profit. Pausing it gives up that lift. Ward called the placing and the pause near-term trade-offs.

He said both fit Informa's long-term approach: return surplus cash to shareholders, and raise money when needed. A CNBC host put the underlying logic plainly, discussing Alphabet's own halt to buybacks. 'Buybacks are what companies do if they don't feel they have productive use for the cash.' Alphabet stopped buying back stock while spending its own cash.

Informa pauses its buyback and also raises new shares and new debt. So Informa is telling shareholders it has found a better use for their money than buying back their shares. Shareholders swap a return already under way for one that depends on Clarion delivering.

What shareholders will own

The bigger change came in the same announcement, and it is not about Clarion. Informa launched a formal process to separate Taylor & Francis, its academic publishing arm. Taylor & Francis made about 17 per cent of Informa's revenue in 2025. Its annual revenue is approaching 1 billion dollars, growing at about 4 per cent.

Informa will review all options and report the outcome with its 2026 full-year results in March 2027. So far, this story has weighed Clarion against the Informa that exists now. Carter said Informa is 'accelerating the focus on our core B2B business'. Shareholders may end up owning a different company: one without its academic arm, built around B2B live events. On growth alone, the swap looks sensible.

Informa's B2B Live Events division grew 8 per cent on an underlying basis in the first half of 2026. Informa says Clarion is growing ahead of the B2B events market. But the academic side earns differently. AD HOC News described Informa's mix as live-event exposure plus recurring content activities. In 2024, Taylor & Francis was boosted by data access deals with AI companies.

In 2025, a lower contribution from those deals hurt its underlying performance. Live events depend on people turning up. The sector was disrupted by the COVID-19 pandemic before roaring back. Carter said Taylor & Francis 'will now benefit from greater flexibility and freedom through the next phase of its development'.

Proactive Investors called it a £2.24 billion bet that Informa's future lies in conference halls rather than journals. That is the shift the share sale pays into. The new shares buy a larger stake in live events, more debt, and possibly less of the content business. So the opening claim needs resetting. Per share, the trade still looks positive on Informa's figures.

But it is a trade into a company more exposed to whether people come to events, and carrying more borrowing. How good an exchange that is also depends on what happens to Taylor & Francis. That answer is still open.

Ahead or behind

Put the pieces together. Informa paid a price an outside expert called broadly in line with comparable deals. Most of it is borrowed, so the dilution is under a tenth of the share count. And on Informa's own forecasts, Clarion's profit more than covers that dilution per share. On that basis, the weight falls on shareholders coming out ahead per share. But that verdict rests on two targets Informa set itself.

One is £50 million of cost savings. The other is keeping net debt below three times EBITDA. The deal still needs regulatory approval, with completion expected towards the end of the fourth quarter. Blackstone is paid in cash. From then on, the risk of missing those targets sits with Informa's shareholders. Back to the opening puzzle: a share sale that, on Informa's numbers, still lifts earnings per share.

I read it as a fair trade for shareholders, but a trade into live events and debt. The first hard test is the debt target. Informa aims for net debt below three times EBITDA at the end of 2026. Its results for that year are due in March 2027, alongside the Taylor & Francis decision. If net debt ends the year above that line, the borrowed part of this deal weighs more than promised. Blackstone keeps its cash.

The extra weight falls on Informa's shareholders, whose slice now carries that debt.

Informational only, not investment advice. Figures and quotes come from the linked reports.